{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T11:31:37Z","timestamp":1725622297896},"publisher-location":"Boston, MA","reference-count":52,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781461372035"},{"type":"electronic","value":"9781461548577"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999]]},"DOI":"10.1007\/978-1-4615-4857-7_60","type":"book-chapter","created":{"date-parts":[[2011,10,18]],"date-time":"2011-10-18T15:44:47Z","timestamp":1318952687000},"page":"397-406","source":"Crossref","is-referenced-by-count":1,"title":["Newer Concepts in Antimicrobial Therapy"],"prefix":"10.1007","author":[{"given":"Lawrence Charles","family":"Parish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"60_CR1","volume-title":"Color Atlas of Cutaneous Infections","author":"LC Parish","year":"1995","unstructured":"Parish L C, Witkowski J A, Vassileva S: Color Atlas of Cutaneous Infections. Boston: Blackwell Scientific, 1995."},{"key":"60_CR2","doi-asserted-by":"crossref","first-page":"115S","DOI":"10.1016\/0002-9343(91)90322-O","volume":"91","author":"L Parish","year":"1991","unstructured":"Parish L C, Jungkind D L: Systemic antimicrobial therapy in skin and skin structure infections: Comparison of temafloxacin and ciprofloxacin. Am J Med; 91:115S-119S. 1991","journal-title":"Am J Med"},{"key":"60_CR3","first-page":"463","volume-title":"Diagnosis and Treatment of Skin Infections","author":"M Harahap","year":"1997","unstructured":"Harahap M: Diagnosis and Treatment of Skin Infections. Oxford: Blackwell Science; 463. 1997"},{"key":"60_CR4","first-page":"370","volume-title":"The Dermatology of Bacterial Infections","author":"GH Findlay","year":"1987","unstructured":"Findlay G H: The Dermatology of Bacterial Infections. Oxford: Blackwell Scientific; 370. 1987"},{"key":"60_CR5","first-page":"309","volume-title":"Global Dermatology","author":"JC Craft","year":"1994","unstructured":"Craft J C: Antimicrobial therapy. In: Parish L C, Milikan L E, ed. Global Dermatology. New York: Springer-Verlag; 309\u2013316. 1994"},{"key":"60_CR6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/00325481.1992.11701319","volume":"91","author":"LC Parish","year":"1992","unstructured":"Parish L C, Witkowski J A: Cutaneous bacterial skin infections: How to manage primary, secondary, and tertiary lesions. Postgrad Med; 91: 119\u2013122, 125-126, 129-130. 1992","journal-title":"Postgrad Med"},{"key":"60_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0190-9622(97)70135-X","volume":"37","author":"ME Epstein","year":"1997","unstructured":"Epstein M E, Amodio-Groton M, Sadick N S: Antimicrobial agents for the dermatologist. II. Macrolides, fluoroquinolones, rifamycins, tetracyclines, trimethoprim-sulfamethoxazole, and clindamycin. J Am Acad Dermatol; 37:365\u201381; quiz 382-4. 1997","journal-title":"J Am Acad Dermatol"},{"key":"60_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0190-9622(97)80118-1","volume":"37","author":"ME Epstein","year":"1997","unstructured":"Epstein M E, Amodio-Groton M, Sadick N S: Antimicrobial agents for the dermatologist. I. Beta-lactam antibiotics and related compounds. J Am Acad Dermatol; 37:149\u201365; quiz 166-6. 1997","journal-title":"J Am Acad Dermatol"},{"key":"60_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/00006454-199702000-00012","volume":"16","author":"GL Darmstadt","year":"1997","unstructured":"Darmstadt G L: Oral antibiotic therapy for uncomplicated bacterial skin infections in children. Pediatr Infect Dis J; 16:227\u201340. 1997","journal-title":"Pediatr Infect Dis J"},{"key":"60_CR10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0190-9622(97)70238-X","volume":"36","author":"KL Chapel","year":"1997","unstructured":"Chapel K L, Rasmussen J E: Pediatric dermatology: advances in therapy. J Am Acad Dermatol; 36:513\u201326; quiz 527-30. 1997","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 1","key":"60_CR11","first-page":"s19","volume":"19","author":"H Keller","year":"1991","unstructured":"Keller H: Adverse reactions to penicillins, tetracyclines, sulfonamides and quinolones. Infection; 19(Suppl 1):s19\u2013s24. 1991","journal-title":"Infection"},{"key":"60_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/clinids\/14.1.285","volume":"14","author":"LD Gentry","year":"1992","unstructured":"Gentry L D: Therapy with newer oral beta-lactam and quinolone agents for infections of the skin and skin structures: A review. Clin Infect Dis; 14:285\u2013297. 1992.","journal-title":"Clin Infect Dis"},{"key":"60_CR13","first-page":"567","volume":"34","author":"LC Parish","year":"1984","unstructured":"Parish L C, Aten E M: Treatment of skin and skin structure infection: A comparative study of Augmentin and Cefaclor. Cutis; 34:567\u2013570. 1984","journal-title":"Cutis"},{"key":"60_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1365-4362.1987.tb00544.x","volume":"26","author":"EJC Goldstein","year":"1987","unstructured":"Goldstein E J C: Outpatient therapy of bite wounds: Demographic data, bacteriology and a prospective randomised trial of amoxicillin\/clavulanic acid versus penicillin \u00b1 dicloxacillin. Int J Dermatol; 26:123\u2013127. 1987","journal-title":"Int J Dermatol"},{"key":"60_CR15","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1128\/AAC.32.8.1143","volume":"32","author":"EJ Goldstein","year":"1988","unstructured":"Goldstein E J, Citron D M: Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds. Antimicrob Agents Chemother; 32:1143\u20131148. 1988","journal-title":"Antimicrob Agents Chemother"},{"key":"60_CR16","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1365-4362.1993.tb02800.x","volume":"32","author":"A Gomez","year":"1993","unstructured":"Gomez A, Saul A, Bonifaz A et al: Amoxicillin and clavulanic acid in the treatment of actinomycetoma. Int J Dermatol; 32:218\u2013220. 1993","journal-title":"Int J Dermatol"},{"key":"60_CR17","doi-asserted-by":"crossref","first-page":"155S","DOI":"10.1016\/S0002-9343(20)31157-8","volume":"94","author":"RD Powers","year":"1993","unstructured":"Powers R D: Open trial of oral fleroxacin versus amoxicillin.clavulanate in the treatment of infections of skin and soft tissue. Am J Med; 94(suppl 3A): 155S\u2013158S. 1993","journal-title":"Am J Med"},{"key":"60_CR18","doi-asserted-by":"crossref","first-page":"150S","DOI":"10.1016\/S0002-9343(20)31156-6","volume":"94","author":"JW Smith","year":"1993","unstructured":"Smith J W, Nichols R L: Comparison of oral fleroxacin with oral amoxicillin\/clavulanate for treatment of skin and soft tissue infections. Am J Med; 94(Suppl 3A):150S\u2013154S. 1993","journal-title":"Am J Med"},{"key":"60_CR19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.2165\/00003495-199039020-00008","volume":"39","author":"PA Todd","year":"1990","unstructured":"Todd P A, Benfield P: Amoxicillin\/clavulanic acid: An update of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 39:264\u2013307. 1990","journal-title":"Drugs"},{"key":"60_CR20","first-page":"179","volume-title":"Infectious Diseases","author":"RC Moellering","year":"1992","unstructured":"Moellering R C, Sentochnik D E: Cephalosporins In: Gorbach S L, Bartlett J G, Blacklow N R:, ed. Infectious Diseases. Philadelphia: W B Saunders, 179\u2013180. 1992"},{"key":"60_CR21","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1365-4362.1986.tb02239.x","volume":"25","author":"LC Parish","year":"1986","unstructured":"Parish L C, Witkowski J A, Snow R et al: Cephalosporins in cutaneous infections: A prospective comparison of two dosage regimens of certazidine for therapy of skin and skin structure infections. Int J Dermatol 25:258\u2013265. 1986","journal-title":"Int J Dermatol"},{"key":"60_CR22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/0738-081X(91)90074-U","volume":"9","author":"LC Parish","year":"1991","unstructured":"Parish L C, Witkowski J A: Cephalosporin therapy in dermatologic practice. Clin Dermatol 9:459\u2013470. 1991","journal-title":"Clin Dermatol"},{"key":"60_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0732-8893(93)90006-S","volume":"16","author":"DL Stevens","year":"1993","unstructured":"Stevens D L, Pien F, Drehobl M: Comparison of oral cefpodoxime proxetil and cefaclor in the treatment of skin and soft tissue infections. Diagn Microbial Infect Dis 16:123\u2013129. 1993","journal-title":"Diagn Microbial Infect Dis"},{"key":"60_CR24","doi-asserted-by":"publisher","first-page":"S255","DOI":"10.1093\/clinids\/14.Supplement_2.S255","volume":"14","author":"TM Nolen","year":"1992","unstructured":"Nolen T M: Clinical trials of cefprozil for treatment of skin and skin structure infections: A review. Clin Infect Dis 14(Suppl 2):S255\u2013263. 1992","journal-title":"Clin Infect Dis"},{"key":"60_CR25","first-page":"458","volume":"14","author":"LC Parish","year":"1992","unstructured":"Parish L C, Doyle C A, Durham S J et al: Cefprozil versus cefaclor in the treatment of mild to moderate skin and skin-structure infections. Clin Ther 14:458\u2013469. 1992","journal-title":"Clin Ther"},{"key":"60_CR26","first-page":"157","volume":"9","author":"E Solomon","year":"1992","unstructured":"Solomon E, McCarty J M, Morman M R et al: Comparison of cefprozil and amioxicillin\/clavulanate potassium in the treatment of skin and skin structure infections in adults. Adv Therapy 9:157\u2013165. 1992","journal-title":"Adv Therapy"},{"key":"60_CR27","first-page":"57","volume":"9","author":"G Wachs","year":"1992","unstructured":"Wachs G, Rogan M P: Cefprozil vs. Erythromycin for mild to moderate skin and skin structure infections. Infect Med 9 (Suppl E):57\u201365. 1992","journal-title":"Infect Med"},{"key":"60_CR28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2165\/00003495-199345020-00008","volume":"45","author":"LR Wiseman","year":"1993","unstructured":"Wiseman L R, Benfield P: Cefprozil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs 45:295\u2013317. 1993","journal-title":"Drugs"},{"key":"60_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0732-8893(92)90055-X","volume":"15","author":"DJ Hardy","year":"1992","unstructured":"Hardy D J, Guay D R, Jones R N: Clarithromycin, a unique macrolide: A pharmacokinetic, microbiological and clinic overview. Diagn Microbiol Infect Dis 15:39\u201353. 1992","journal-title":"Diagn Microbiol Infect Dis"},{"key":"60_CR30","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1365-4362.1993.tb02843.x","volume":"32","author":"LC Parish","year":"1993","unstructured":"Parish L C et al: Clarithromycin in the treatment of skin and skin structure infections: Two multicenter clinical studies. Int J Dermatol 32:528\u2013532. 1993","journal-title":"Int J Dermatol"},{"key":"60_CR31","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1177\/106002809202600912","volume":"26","author":"MG Sturgill","year":"1992","unstructured":"Sturgill M G, Rapp R P: Clarithromycin: Review of a new macrolide antibiotic with improved microbiologic spectrum and favorable pharmacokinetic and adverse effect profiles. Ann Pharmacother 26:1099\u20131108. 1992","journal-title":"Ann Pharmacother"},{"key":"60_CR32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/030006059101900602","volume":"19","author":"R Daniel","year":"1991","unstructured":"Daniel R et al: Azithromycin, erythromycin and cloxacillin in the treatment of infections of skin and associated soft tissues. J Int Med Res 19:433\u2013445. 1991","journal-title":"J Int Med Res"},{"key":"60_CR33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/j.1875-9114.1992.tb04504.x","volume":"12","author":"RH Drew","year":"1992","unstructured":"Drew R H, Gallis H A: Azithromycin \u2014 Spectrum of activity, pharmacokinetics and clinical applications. Pharmacotherapy 12:161\u2013173. 1992","journal-title":"Pharmacotherapy"},{"key":"60_CR34","first-page":"880","volume":"10","author":"R Kiani","year":"1991","unstructured":"Kiani R: Double-blind, double-dummy comparison of azithromycin and cephalexin in the treatment of skin and skin structure infections. 10:880\u2013884. 1991","journal-title":"Double-blind, double-dummy comparison of azithromycin and cephalexin in the treatment of skin and skin structure infections"},{"key":"60_CR35","doi-asserted-by":"publisher","first-page":"36S","DOI":"10.1016\/0002-9343(91)90400-R","volume":"91","author":"SB Mallory","year":"1991","unstructured":"Mallory S B: Azithromycin compared with cephalexin in the treatment of skin and skin structure infection. Am J Med 91 (Suppl 3A):36S\u201339S. 1991","journal-title":"Am J Med"},{"key":"60_CR36","doi-asserted-by":"publisher","first-page":"750","DOI":"10.2165\/00003495-199244050-00007","volume":"44","author":"DH Peters","year":"1992","unstructured":"Peters D H, Fiedel H A, McTavish D: Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs 44:750\u2013799. 1992","journal-title":"Drugs"},{"key":"60_CR37","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1086\/646545","volume":"13","author":"MS Whitman","year":"1992","unstructured":"Whitman M S, Tunkel A R: Azithromycin and clarithromycin: Overview and comparison with erythromycin. Infect Control Hosp Epidemiol 13:357\u2013368. 1992","journal-title":"Infect Control Hosp Epidemiol"},{"key":"60_CR38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/jac\/31.suppl_C.159","volume":"31","author":"M Derriennic","year":"1993","unstructured":"Derriennic M, Escande J P: Drithromycin in the treatment of skin and skin structure infections. J Antimicrob Chemothr 31 (Suppl C): 159\u2013168. 1993","journal-title":"J Antimicrob Chemothr"},{"key":"60_CR39","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0924-8579(93)90052-7","volume":"2","author":"A Bryskier","year":"1993","unstructured":"Bryskier A: Fluoroquinolones: Mechanisms of action and resistance. Int J Antimicrob Ag 2:151\u2013184. 1993","journal-title":"Int J Antimicrob Ag"},{"key":"60_CR40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/jac\/28.suppl_C.97","volume":"28","author":"LD Gentry","year":"1991","unstructured":"Gentry L D: Review of quinolones in the treatment of infections of the skin and skin structure. J Antimicrob Chemother 28(Suppl C): 97\u2013100. 1991","journal-title":"J Antimicrob Chemother"},{"key":"60_CR41","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1056\/NEJM199102073240606","volume":"324","author":"DC Hooper","year":"1991","unstructured":"Hooper D C, Wolfson J S: Fluoroquinolone antimicrobial agents. N Engl J Med 324:384\u2013394. 1991","journal-title":"N Engl J Med"},{"key":"60_CR42","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1365-4362.1986.tb03418.x","volume":"25","author":"LC Parish","year":"1986","unstructured":"Parish L C, Witkowski J A: The quinolones and dermatologic practice. Int J Dermatol 25:351\u2013356. 1986","journal-title":"Int J Dermatol"},{"key":"60_CR43","first-page":"243","volume-title":"The New Generation of Quinolones","author":"LC Parish","year":"1990","unstructured":"Parish L C, Witkowski J A: Quinolones and cutaneous disease. In: Siporin C, Heifetz C L, Domagala J M: ed. The New Generation of Quinolones. New York: Marcel Dekker, 243\u2013248. 1990"},{"key":"60_CR44","first-page":"227","volume":"82","author":"LC Parish","year":"1987","unstructured":"Parish L C, Asper R: Systemic treatment of cutaneous infections: A comparative study of ciprofloxacin and cefotaxime. Am J Med 82 (Suppl 4A):227\u2013229. 1987","journal-title":"Am J Med"},{"key":"60_CR45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1365-4362.1988.tb01295.x","volume":"27","author":"LC Parish","year":"1988","unstructured":"Parish L C, Witkowski J A, Jungkind D L et al: Treatment of cutaneous infections: Worldwide experience with ciprofloxacin. Int J Dermatol 27:131\u2013133. 1988","journal-title":"Int J Dermatol"},{"key":"60_CR46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0924-8579(91)90002-U","volume":"1","author":"PM Shah","year":"1991","unstructured":"Shah P M: Ciprofloxacin. Int J Antimicrob Agents 1:75\u201396. 1991","journal-title":"Int J Antimicrob Agents"},{"key":"60_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0926-9959(94)00068-B","volume":"4","author":"YM Mirensky","year":"1995","unstructured":"Mirensky Y M, Parish L C: Photosensitivity and the quinolones. J Eur Acad Dermatol Venereol 4:1\u20134. 1995","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"60_CR48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/j.1875-9114.1988.tb04063.x","volume":"8","author":"RH Drew","year":"1988","unstructured":"Drew R H, Gallis H A: Ofloxacin: Its pharmacology, pharmacokinetics and potential for clinical application. Pharmacotherapy 8:35\u201346. 1988","journal-title":"Pharmacotherapy"},{"key":"60_CR49","first-page":"55","volume":"51","author":"LD Gentry","year":"1993","unstructured":"Gentry L D, Rodriquez-Gomez G: Ofloxacin treatment of difficult infections of the skin and skin structure. Cutis 51:55\u201358. 1993","journal-title":"Cutis"},{"key":"60_CR50","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1365-4362.1992.tb02683.x","volume":"31","author":"BA Lipsky","year":"1992","unstructured":"Lipsky B A, Yarbrough D R, 3rd, Walker F B, 4th, et al: Ofloxacin versus cephalexin for treating skin and soft tissue infections. Int J Dermatol 31:443\u2013445. 1992","journal-title":"Int J Dermatol"},{"key":"60_CR51","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0924-8579(91)90001-T","volume":"1","author":"Y Mouton","year":"1991","unstructured":"Mouton Y, Leroy O: Ofloxacin. Int J Antimicrob Agents 1:57\u201374. 1991","journal-title":"Int J Antimicrob Agents"},{"key":"60_CR52","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/clinids\/14.2.539","volume":"14","author":"WE Sanders Jr.","year":"1992","unstructured":"Sanders W E, Jr.: Oral ofloxacin: A critical review of the new drug application. Clin Infect Dis 14:539\u2013554. 1992","journal-title":"Clin Infect Dis"}],"container-title":["Advances in Experimental Medicine and Biology","Rheumaderm"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-4857-7_60.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T15:26:20Z","timestamp":1639236380000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-4857-7_60"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999]]},"ISBN":["9781461372035","9781461548577"],"references-count":52,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-4857-7_60","relation":{},"ISSN":["0065-2598"],"issn-type":[{"type":"print","value":"0065-2598"}],"subject":[],"published":{"date-parts":[[1999]]}}}